Respiratory/Pulmonary Market Research Reports & Industry Analysis
Respiratory/Pulmonary Industry Research & Market Reports
-
2025 Diseases of the Respiratory System Global Market Size & Growth Report with Updated Analysis & Forecasts
... 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the respiratory system ... Read More
-
Respiratory Diagnostics Market by Product & Services (Instrument & Devices), Test type (Mechanical, OSA, Imaging, Molecular Test), Disease (Tuberculosis, COPD, Lung Cancer ) and Diagnosis Type (Syndromic, Aetiological, Prognosis) - Global Forecast to 2030
... by many rising impacts with respect to improving cases of respiratory diseases around the world. Innovative technologies in diagnosis, such as molecular diagnostics and advanced imaging solutions, have also improved the accuracy and speed of ... Read More
-
Cephalosporin Market Report by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), Route of Administration (Injection, Oral), Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), and Region 2025-2033
... market is experiencing steady growth driven by increasing antibiotic-resistant infections, the demand for effective and safer treatment options, ongoing research and development efforts to introduce new cephalosporin formulations, and rising awareness among healthcare professionals regarding ... Read More
-
Respiratory Diagnostics
... CAGR of 4.5% over the analysis period 2024-2030. Respiratory Diagnostic Instruments & Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$5.1 Billion by the end ... Read More
-
Airway Clearance Systems
... at a CAGR of 4.7% over the analysis period 2024-2030. Positive Expiratory Pressure (PEP) Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$396.2 Million by ... Read More
-
Respiratory Protection Equipment
... at a CAGR of 6.4% over the analysis period 2024-2030. Air Purifying Respirators, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$15.3 Billion by the end ... Read More
-
Extracorporeal CO2 Removal Devices
... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$89.9 Million by ... Read More
-
Respiratory Inhalers
... CAGR of 6.0% over the analysis period 2024-2030. Manual Respiratory Inhalers, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$54.4 Billion by the end of the ... Read More
-
Non-Small Cell Lung Cancer (NSCLC) Therapeutics
... reach US$54.0 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach ... Read More
-
Therapeutic Respiratory Devices
... at a CAGR of 3.3% over the analysis period 2024-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$32.3 Billion by the ... Read More
-
Idiopathic Pulmonary Fibrosis
... at a CAGR of 5.7% over the analysis period 2024-2030. Pirfenidone, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$4.8 Billion by the end of the ... Read More
-
Hospital Acquired Infection Treatment
... 2030, growing at a CAGR of 2.7% over the analysis period 2024-2030. Urinary Tract Infections, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$31.7 Billion by ... Read More
-
Cryptococcosis Treatment
... CAGR of 4.5% over the analysis period 2024-2030. Amphotericin B Treatment, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
Pulmonary / Respiratory Drug Delivery
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Metered Dose Inhalers, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$35.9 ... Read More
-
Bovine Respiratory Disease Treatment
... 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Vaccines, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$1.4 Billion by the end ... Read More
-
Lung Cancer Therapeutics
... at a CAGR of 10.8% over the analysis period 2024-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach US$82.3 Billion by ... Read More
-
Transcatheter Pulmonary Valves
... at a CAGR of 5.8% over the analysis period 2024-2030. Balloon-Expanded Technology, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$74.1 Million by the end of ... Read More
-
Global Acute Respiratory Distress Syndrome Treatment Market 2025-2029
... report on the acute respiratory distress syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
2024-2029 Finland Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, ... Read More
-
2024-2029 Russia Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, ... Read More
-
2024-2029 Colombia Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, ... Read More
-
2024-2029 New Zealand Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... the 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, ... Read More
-
2024-2029 Slovenia Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, ... Read More
-
2024-2029 Panama Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, ... Read More
-
2024-2029 Indonesia Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, ... Read More
Research Assistance
